• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射芬太尼的动力学

Intravenous fentanyl kinetics.

作者信息

McClain D A, Hug C C

出版信息

Clin Pharmacol Ther. 1980 Jul;28(1):106-14. doi: 10.1038/clpt.1980.138.

DOI:10.1038/clpt.1980.138
PMID:7389247
Abstract

Fentanyl is considered to be a short-acting narcotic analgesic but prolonged and recurrent ventilatory depression has been reported. We examined fentanyl kinetics and excretion in 7 healthy male subjects who were given a 3.2- or 6.4-micrograms/kg dose of 3H-fentanyl intravenously. Arterial blood and urine samples were analyzed for unchanged fentanyl and total radioactivity. Fentanyl concentrations fell rapidly and 98.6% of the dose was eliminated from plasma in 60 min but the terminal elimination phase of fentanyl from the body was slow (t1/2 beta = 219 min) due to the slow return of the unchanged drug from a peripheral compartment to the central compartment where elimination occurred primarily by biotransformation. Eighty-five percent of the dose was recovered in urine and feces in 72 hr; less than 8% was recovered as unchanged fentanyl. There were fluctuations in plasma fentanyl levels during the elimination phase in all cases. The long t1/2 beta and fluctuations in plasma levels may contribute to prolonged and recurrent ventilatory effects of fentanyl.

摘要

芬太尼被认为是一种短效麻醉性镇痛药,但已有报道称其会导致长时间和反复的呼吸抑制。我们对7名健康男性受试者进行了研究,他们静脉注射了3.2或6.4微克/千克剂量的³H-芬太尼,我们检测了芬太尼的动力学和排泄情况。对动脉血和尿液样本进行分析,以检测未变化的芬太尼和总放射性。芬太尼浓度迅速下降,60分钟内98.6%的剂量从血浆中消除,但芬太尼从体内的终末消除阶段较慢(t1/2β = 219分钟),这是因为未变化的药物从外周室缓慢返回中央室,而在中央室主要通过生物转化进行消除。72小时内85%的剂量在尿液和粪便中回收;回收的未变化芬太尼不到8%。在所有情况下,消除阶段血浆芬太尼水平都有波动。较长的t1/2β和血浆水平波动可能导致芬太尼产生长时间和反复的呼吸效应。

相似文献

1
Intravenous fentanyl kinetics.静脉注射芬太尼的动力学
Clin Pharmacol Ther. 1980 Jul;28(1):106-14. doi: 10.1038/clpt.1980.138.
2
Pharmacokinetics of 3H-fentanyl in the dog anesthetized with enflurane.3H-芬太尼在恩氟烷麻醉犬体内的药代动力学。
Anesthesiology. 1979 Jan;50(1):13-9. doi: 10.1097/00000542-197901000-00004.
3
Dose-independent pharmacokinetics of fentanyl.芬太尼的非剂量依赖性药代动力学。
Anesthesiology. 1983 Dec;59(6):537-40. doi: 10.1097/00000542-198312000-00009.
4
Pharmacokinetics of alfentanil in man.阿芬太尼在人体中的药代动力学。
Anesth Analg. 1982 Aug;61(8):657-61.
5
Tissue redistribution of fentanyl and termination of its effects in rats.芬太尼在大鼠体内的组织再分布及其作用的终止
Anesthesiology. 1981 Oct;55(4):369-75. doi: 10.1097/00000542-198110000-00006.
6
Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression.芬太尼的药代动力学可能是呼吸抑制复发的一个解释。
Br J Anaesth. 1979 Aug;51(8):741-5. doi: 10.1093/bja/51.8.741.
7
[Pharmacokinetics of [3H]ohmefentanyl in rats].[大鼠体内[3H]奥芬太尼的药代动力学]
Zhongguo Yao Li Xue Bao. 1990 Sep;11(5):406-11.
8
Pharmacokinetics of fentanyl in neonates.芬太尼在新生儿中的药代动力学。
Anesth Analg. 1986 Mar;65(3):227-32.
9
Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography--mass spectrometry.采用气相色谱-质谱联用技术对患者体内芬太尼代谢物进行鉴定和定量测定。
Anesthesiology. 1984 Jul;61(1):73-7.
10
Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies.健康人体中β-甲基地高辛的药代动力学I:静脉注射研究
J Pharm Sci. 1977 Feb;66(2):242-53. doi: 10.1002/jps.2600660228.

引用本文的文献

1
Anesthetic Management With Remimazolam for Adolescent Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-like Episodes (MELAS): A Case Report.咪达唑仑用于青少年线粒体脑肌病伴乳酸酸中毒和卒中样发作(MELAS)的麻醉管理:一例报告
Anesth Prog. 2025 Mar 12;72(1):46-48. doi: 10.2344/23-0051.
2
Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models.使用动态年龄依赖性生理药代动力学模型预测儿科和老年患者中CYP3A4代谢药物的药代动力学
Pharmaceutics. 2025 Feb 7;17(2):214. doi: 10.3390/pharmaceutics17020214.
3
Effect of changes in skin properties due to diabetes mellitus on the titration period of transdermal fentanyl: single-center retrospective study and diabetic animal model study.
糖尿病导致的皮肤特性变化对透皮芬太尼滴定期的影响:单中心回顾性研究及糖尿病动物模型研究
J Pharm Health Care Sci. 2024 Dec 18;10(1):80. doi: 10.1186/s40780-024-00402-5.
4
Abuse potential of fentanyl and fentanyl analogues.芬太尼及芬太尼类似物的滥用可能性。
Bioimpacts. 2024;14(6):27691. doi: 10.34172/bi.2024.27691. Epub 2024 Mar 18.
5
Serotonin Syndrome Induced by Fentanyl Alone in an Adult Patient After Cardiac Surgery: A Case Report.成人心脏手术后单纯芬太尼诱发血清素综合征:一例报告
Cureus. 2024 Jul 18;16(7):e64832. doi: 10.7759/cureus.64832. eCollection 2024 Jul.
6
The Psychiatrist's Role in Treating Perinatal Opioid Use Disorder and Reducing Maternal Mortality.精神科医生在治疗围产期阿片类药物使用障碍及降低孕产妇死亡率方面的作用。
Focus (Am Psychiatr Publ). 2024 Jan;22(1):25-34. doi: 10.1176/appi.focus.20230018. Epub 2024 Jan 12.
7
In Vitro Hepatotoxicity of Routinely Used Opioids and Sedative Drugs.常用阿片类药物和镇静药物的体外肝毒性
Curr Issues Mol Biol. 2024 Mar 30;46(4):3022-3038. doi: 10.3390/cimb46040189.
8
Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl.低浓度芬太尼和/或去甲芬太尼标本中诺芬太尼免疫分析法的性能。
J Appl Lab Med. 2024 Sep 3;9(5):895-904. doi: 10.1093/jalm/jfae036.
9
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl.芬太尼的吸收、分布、代谢和排泄:与非法制造的芬太尼相关的叙述性综述及临床意义。
J Addict Med. 2023;17(5):503-508. doi: 10.1097/ADM.0000000000001185. Epub 2023 May 17.
10
Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine.病例报告:用大剂量丁丙诺啡治疗丁丙诺啡诱发的芬太尼戒断。
F1000Res. 2023 Aug 10;11:487. doi: 10.12688/f1000research.120821.2. eCollection 2022.